{
    "nct_id": "NCT05786014",
    "official_title": "A Feasibility Study to Examine Two Remotely-monitored Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies",
    "inclusion_criteria": "* Age 18 years or over\n* diagnosis of breast cancer (Stage I-III or IV with minimal burden) and prescribed chemotherapy (TC (Docetaxel/Cyclophosphamide), AC (Doxorubicin/Cyclophosphamide followed by Paclitaxel), TCHP (Docetaxel, Carboplatin, Trastuzumab, Pertuzumab), TCH (Docetaxel/Carboplatin/Trastuzumab) with or without Pembrolizumab)\n* Physician clearance for exercise training\n* Speak/understand English\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* previous treatment with cardiotoxic chemotherapy\n* medical/orthopedic comorbidities that preclude stationary cycling\n* significant cardiac/renal/hepatic/hematological/pulmonary disease precluding exercise training\n* unstable angina or myocardial infarction within 4-weeks prior to treatment\n* complex ventricular arrhythmias or New York Heart Association class IV symptoms\n* symptomatic severe aortic stenosis\n* acute pulmonary embolus\n* acute myocarditis\n* History of untreated high-risk proliferative retinopathy\n* History of retinal hemorrhage\n* uncontrolled hypertension (systolic blood pressure > 180 mm Hg or diastolic blood pressure > 120 mm Hg)\n* severe baseline electrolyte abnormalities\n* medication non-compliance\n* uncontrolled metabolic disease (diabetes with fasting blood sugar >300 mg/dl, thyrotoxicosis, myxedema)\n* symptomatic peripheral vascular disease\n* Pregnant women",
    "miscellaneous_criteria": ""
}